Spaulding Clinical: Neal Collins, medical director
By Jenni Spinner
- Last updated on
Spaulding Clinical has hired Neal Collins as medical director. Collins—whose experience includes serving in senior positions at Merck, AstraZeneca and Pfizer—will lead medical staff and oversee Phase I studies from the firm’s Spaulding’s West Bend, Wis., clinical pharmacology unit.
Spaulding Clinical CEO Cassandra Erato said, “As a leader in Phase I-IV clinical trials oversight as well as regulatory alignment and strategy, his wealth of experience in both global and U.S. markets makes him a valuable addition. His broad therapeutic expertise — spanning oncology, internal medicine, primary care, infectious disease, vaccines, women’s health and endocrinology — will be especially valuable during this time of growth for Spaulding.”